Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 2, 2008, Pages

  Kato, Shunji ^a   Matsukura, Norio ^a   Matsuda, Noriko ^a   Tsuchiya, Shinichi ^b   Naito, Zenya ^a   Tajiri, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Chronic atrophic gastritis; Eradication of H. pylori; Gastric juice pH level; Remnant stomach; Updated Sydney System

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II; PROTON PUMP INHIBITOR;

ADULT; AGED; BACTERIAL INFECTION; CONFERENCE PAPER; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GASTRECTOMY; HELICOBACTER PYLORI; HUMAN; INTESTINE ANASTOMOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH PH;

EID: 57449112537     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05447.x     Document Type: Conference Paper

References (25)

1. Malfertheiner P, Mégraud F, O'Morain C et al. The European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 2002 16 : 167 80.
2. Nakagawa S, Asaka M, Kato M et al. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Aliment. Pharmacol. Ther. 2006 24 (Suppl. 4 214 18.
3. Guideline for H. pylori the Japanese Society of Helicobacter published diagnosis and treatment in February 2003. Helicobacter 2003 4 : 2 7 (in Japanese).
4. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996 20 : 1161 81.
5. Genta RM, Rugge M. Assessing risks for gastric cancer: new tools for pathologists. World J. Gastroenterol. 2006 12 : 5622 7.
6. Asaka M, Kato M, Kudo M et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur. J. Gastroenterol. Hepatol. 1995 7 : S7 10.
7. Ohata H, Oka M, Yanaoka K et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci. 2005 96 : 713 20.
8. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006 9 : 245 53.
9. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand. J. Gastroenterol. 2007 42 : 2 10.
10. Taguchi Y, Kaito M, Gabazza EC et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural study. Scand. J. Gastroenterol. 1997 32 : 656 63.
11. Shiotani A, Iishi H, Kumamoto M, Nakae Y. Helicobacter pylori infection and increased nitrite synthesis in the stomach. Inflammation and atrophy connections. Dig. Liver Dis. 2004 36 : 327 32.
12. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM. Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects. Helicobacter 2003 8 : 29 35.
13. Matsukura N, Tajiri T, Kato S et al. Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric Cancer 2003 6 : 100 7.
14. Togashi A, Matsukura N, Kato S et al. Simple and accurate (13)C-urea breath test for detection of Helicobacter pylori in the remnant stomach after surgery. J. Gastroenterol. 2006 41 : 127 32.
15. Matsukura N, Onda M, Tokunaga A et al. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer and gastric cancer. J. Clin. Gastroenterol. 1993 17 : s146 50.
16. Naylor G, Axon A. Role of bacterial overgrowth in the stomach as an additional risk factor for gastritis. Can. J. Gastroenterol. 2003 17 : 13B 17B.
17. Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC. Gastric stump cancer: what is the risk? Dig. Dis. 1998 16 : 159 68.
18. Tomtitchong P, Onda M, Matsukura N et al. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses. J. Clin. Gastroenterol. 1998 27 (Suppl. 1 S154 8.
19. Lee Y, Tokunaga A, Tajiri T et al. Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection. J. Gastroenterol. 2004 39 : 520 6.
20. Sharma P, Vakil N. Helicobacter pylori and reflux disease. Aliment. Pharmacol. Ther. 2003 17 : 297 305.
21. Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res. 1997 17 (5B 3893 6.
22. Annibale B, Di Giulio E, Caruana P et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment. Pharmacol. Ther. 2002 16 : 1723 31.
23. Chiba T, Watanabe T, Ito T. Helicobacter pylori infection and acid secretion in patients with duodenal ulcer in Japan. Gut 2001 48 : 871 2.
24. Kato S, Matsukura N, Matsuda N, Tsukada K, Naito Z, Tajiri T. Helicobacter pylori eradication therapy modulates acidity and interleukin-1beta mRNA levels in unoperated stomach and in remnant stomach after gastrectomy in gastric cancer patients. Aliment. Pharmacol. Ther. 2006 24 (Suppl. 4 278 84.
25. Saito D. H. pylori and gastric premalignant conditions. Results of the Japanese intervention trial. AACR Frontiers in Cancer Prevention Research (Abstract). 2005 201.